Clinical Trial: Low-dose aspirin for the prevention of tumor recurrence and metastasis after liver transplantation for hepatocellular carcinoma (China)

Posted On: 2026-10-12

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Low-dose aspirin for the prevention of tumor recurrence and metastasis after liver transplantation for hepatocellular carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133944

Registration Time: 2026/10/09

Type: Interventional study

Primary Sponsor: The Third Affiliated Hospital Sun Yat-sen University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346558

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Low-dose aspirin for the prevention of tumor recurrence and metastasis after liver transplantation for hepatocellular carcinoma (China)